Scientists hunt for hidden signs to guide pancreatic cancer treatment
NCT ID NCT07271823
Summary
This study aims to understand why some patients with advanced pancreatic cancer respond to immunotherapy while others do not. Researchers will collect blood, tissue, and stool samples from 100 patients receiving a standard immunotherapy and chemotherapy combination. By analyzing these samples, they hope to find patterns that can help predict which future patients are most likely to benefit from this type of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER NON-RESECTABLE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)
Zhejiang, Hangzhou, 310022, China
Conditions
Explore the condition pages connected to this study.